Ivanhoe -
5 Sep 2013 07:00
(Ivanhoe Newswire) -A drug that is proven to be effective for treating adults and children with sickle cell anemia has also reduced hospitalizations and cut annual estimated medical costs by 21 percent for affected infants and toddlers, according to researchers at St. Jude Children's Research Hospital.
Share this Article